US Broker Ratings

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 45% Potential Upside in the Booming Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find Globus Medical, Inc. (NASDAQ: GMED) an intriguing prospect. With a market capitalization of $7.93 billion, this U.S.-based..

BrightSpring Health Services, Inc. (BTSG) Investor Outlook: Analyzing a 19% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a key player in the Health Information Services industry, presents a compelling investment opportunity within the healthcare sector. With a market..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unpacking a 61% Potential Upside in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out in the healthcare sector, particularly within the medical devices industry, due to its innovative approach to tackling obstructive..

Guardant Health, Inc. (GH) Stock Analysis: 17% Upside Potential Amidst Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH) continues to capture investor attention as it solidifies its position within the healthcare sector, specifically in the diagnostics and research industry...

Telix Pharmaceuticals Limited (TLX): Investor Outlook and Potential Upside of Over 42%

Telix Pharmaceuticals Limited (ASX: TLX) is capturing significant attention in the biotechnology sector with its promising portfolio of radiopharmaceuticals aimed at treating cancer and rare diseases...

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Uncovering a 39.93% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a major player in the healthcare sector, is captivating investor attention with a striking potential upside of nearly 40%. As..

Biogen Inc. (BIIB) Investor Outlook: Navigating an Upside of Over 36% Amidst a Challenging Market

For investors eyeing the healthcare sector, Biogen Inc. (NASDAQ: BIIB) presents a compelling opportunity with a potential upside of 36.58%, according to current analyst ratings. With..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Evaluating a 35.81% Potential Upside

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, particularly within the diagnostics and research industry, stands out as a compelling investment opportunity..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Strong Buy Ratings and 27.73% Upside Potential

Neurocrine Biosciences, Inc. (NBIX) stands out as a compelling investment opportunity within the healthcare sector, specifically in the niche of drug manufacturing for specialty and generic..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking the 16.10% Upside Potential in Healthcare Innovation

Stevanato Group S.p.A. (NYSE: STVN), a pivotal player in the healthcare sector, is capturing investor attention with its robust market presence and burgeoning growth prospects. With..

Walgreens Boots Alliance (WBA) Stock Analysis: Dividend Yield Shines Amidst Challenging Valuation Metrics

As Walgreens Boots Alliance, Inc. (NASDAQ: WBA) navigates the complexities of the healthcare sector, investors are taking a close look at its financial health and market..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 21% Potential Upside in Medical Device Innovation

Integer Holdings Corporation (NYSE: ITGR) is carving its niche in the healthcare sector, providing cutting-edge solutions in the medical devices industry. With a market capitalization of..

Masimo Corporation (MASI) Stock Analysis: Navigating the Market with a 9.23% Upside Potential

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector, is capturing attention with its innovative medical devices. The company, based in Irvine, California, has..

iRhythm Technologies, Inc. (IRTC): Investor Outlook on a Leading Digital Healthcare Innovator

For investors keen on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out as a noteworthy player in the realm of medical devices. With a..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 44.86% Potential Upside in Biotech Innovation

Investors are turning their attention to Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading biotechnology firm in the healthcare sector, as it continues to make significant strides..

Cardinal Health, Inc. (CAH) Investor Outlook: A Closer Look at Its 3.01% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) is a significant player in the healthcare sector, primarily focusing on medical distribution. With a robust presence in the United States..

Chemed Corp (CHE) Stock Analysis: Unlocking a 15.61% Potential Upside in the Healthcare Sector

Chemed Corporation (NYSE: CHE), a notable player in the healthcare sector, is capturing investor attention with its unique dual-segment business model and promising growth potential. With..

Baxter International Inc. (BAX) Stock Analysis: 26% Upside Potential Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, presents an intriguing opportunity for investors with its substantial potential upside. The company’s diverse portfolio..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Closer Look at Its Robust Return on Equity and Revenue Growth

Medpace Holdings, Inc. (MEDP), a key player in the healthcare sector, stands out in the diagnostics and research industry. With a market capitalization of $8.93 billion,..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 29.78% Potential Upside in the Biotech Sector

Bio-Techne Corporation (NASDAQ: TECH), a key player in the biotechnology sector, has established a robust presence in the healthcare industry with a market capitalization of $8.13..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds